Chemical Name: N-((1S,2R)-2-(2,3-difluorophenyl)cyclopropyl)-N-(3-((1S,2R,3R,4R)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)nitrous amide
Smiles: O=NN([C@@H]1[C@@H](C2=CC=CC(F)=C2F)C1)C3=C(N=NN4[C@@H]5[C@@H](O)[C@@H](O)[C@H](OCCO)C5)C4=NC(SCCC)=N3
Inchi: InChI=1S/C6H13N3O3/c1-9(2,3)8(7-12)5-4-6(10)11/h4-5H2,1-3H3
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42